Tampa General Hospital gets new Covid-19 treatment
November 19, 2020 - Tampa General Hospital said it is one of the first hospitals in the United States to provide monoclonal antibody treatments to some patients with Covid-19. The treatment from Eli Lilly (NYSE: LLY) was recently approved by the U.S. Food and Drug Administration under an emergency use authorization. It's for the treatment of patients with mild to moderate symptoms from Covid-19 before they deteriorate further or require hospitalization. It is a single dose infusion-based treatment that is provided on an outpatient basis and marks a dramatic shift in Covid-19 care, a news release from Tampa General said. Production is just ramping up and there is a limited supply of the treatment, so physicians are only approving its use on high-risk patients, the hospital said. Tampa General received some of the first supplies in the country and has the option to request additional doses on a weekly basis, the hospital said.